BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17711861)

  • 1. Glycogen synthase kinase-3beta induces neuronal cell death via direct phosphorylation of mixed lineage kinase 3.
    Mishra R; Barthwal MK; Sondarva G; Rana B; Wong L; Chatterjee M; Woodgett JR; Rana A
    J Biol Chem; 2007 Oct; 282(42):30393-405. PubMed ID: 17711861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of casein kinase II and inhibition of phosphatase and tensin homologue deleted on chromosome 10 phosphatase by nerve growth factor/p75NTR inhibit glycogen synthase kinase-3beta and stimulate axonal growth.
    Arevalo MA; Rodríguez-Tébar A
    Mol Biol Cell; 2006 Aug; 17(8):3369-77. PubMed ID: 16723502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibition.
    Santo L; Vallet S; Hideshima T; Cirstea D; Ikeda H; Pozzi S; Patel K; Okawa Y; Gorgun G; Perrone G; Calabrese E; Yule M; Squires M; Ladetto M; Boccadoro M; Richardson PG; Munshi NC; Anderson KC; Raje N
    Oncogene; 2010 Apr; 29(16):2325-36. PubMed ID: 20101221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of glycogen synthase kinase-3β in glioma cell apoptosis induced by remifentanil.
    Xu J; Xu P; Li Z; Xiao L; Yang Z
    Cell Mol Biol Lett; 2013 Dec; 18(4):494-506. PubMed ID: 23990403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PPLA motif of glycogen synthase kinase 3beta is required for interaction with Fe65.
    Lee EJ; Hyun S; Chun J; Shin SH; Lee KE; Yeon KH; Park TY; Kang SS
    Mol Cells; 2008 Jul; 26(1):100-5. PubMed ID: 18547980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of MLK3 in the regulation of mitogen-activated protein kinase signaling cascades.
    Brancho D; Ventura JJ; Jaeschke A; Doran B; Flavell RA; Davis RJ
    Mol Cell Biol; 2005 May; 25(9):3670-81. PubMed ID: 15831472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of junctional adhesion molecule-A prevents spontaneous and random motility.
    Bazzoni G; Tonetti P; Manzi L; Cera MR; Balconi G; Dejana E
    J Cell Sci; 2005 Feb; 118(Pt 3):623-32. PubMed ID: 15657074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disrupting PIAS3-mediated SUMOylation of MLK3 ameliorates poststroke neuronal damage and deficits in cognitive and sensorimotor behaviors.
    Jiang Y; Hu L; Wang B; Zhang B; Shao M; Meng L; Xu Y; Chen R; Li M; Du C
    Cell Mol Life Sci; 2024 Mar; 81(1):119. PubMed ID: 38456949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Versican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapy.
    Du WW; Yang BB; Yang BL; Deng Z; Fang L; Shan SW; Jeyapalan Z; Zhang Y; Seth A; Yee AJ
    PLoS One; 2011; 6(11):e26396. PubMed ID: 22096483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the role of GSK-3β in the brain: from neurodegenerative disease to tumorigenesis.
    Lai S; Wang P; Gong J; Zhang S
    PeerJ; 2023; 11():e16635. PubMed ID: 38107562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Glycogen Synthase Kinase-3β in the Zinc-Mediated Neuroprotective Effect of Metformin in Rats with Glutamate Neurotoxicity.
    Oruc A; Oruc KY; Yanar K; Mengi M; Caglar A; Kurt BO; Altan M; Sonmez OF; Cakatay U; Uzun H; Simsek G
    Biol Trace Elem Res; 2024 Jan; 202(1):233-245. PubMed ID: 37071257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of glioblastoma growth by the thiadiazolidinone compound TDZD-8.
    Aguilar-Morante D; Morales-Garcia JA; Sanz-SanCristobal M; Garcia-Cabezas MA; Santos A; Perez-Castillo A
    PLoS One; 2010 Nov; 5(11):e13879. PubMed ID: 21079728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue.
    Turkistani A; Al-Kuraishy HM; Al-Gareeb AI; Albuhadily AK; Alexiou A; Papadakis M; Elfiky MM; Saad HM; Batiha GE
    Mol Neurobiol; 2024 Feb; ():. PubMed ID: 38367137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into glycogen synthase kinase-3: A common target for neurodegenerative diseases.
    Wang C; Cui Y; Xu T; Zhou Y; Yang R; Wang T
    Biochem Pharmacol; 2023 Dec; 218():115923. PubMed ID: 37981175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen Synthase Kinase-3 Interaction Domain Enhances Phosphorylation of SARS-CoV-2 Nucleocapsid Protein.
    Yun JS; Song H; Kim NH; Cha SY; Hwang KH; Lee JE; Jeong CH; Song SH; Kim S; Cho ES; Kim HS; Yook JI
    Mol Cells; 2022 Dec; 45(12):911-922. PubMed ID: 36572560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 625 nm light-emitting diode irradiation on preventing ER stress-induced apoptosis via GSK-3β phosphorylation in MC3T3-E1.
    Fu W; Liu G; Kim SH; Kim B; Kim OS; Ma G; Yang Y; Liu D; Zhu S; Kang JS; Kim O
    Photochem Photobiol; 2024 Jan; ():. PubMed ID: 38214077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSK-3β Contributes to Parkinsonian Dopaminergic Neuron Death: Evidence From Conditional Knockout Mice and Tideglusib.
    Li J; Ma S; Chen J; Hu K; Li Y; Zhang Z; Su Z; Woodgett JR; Li M; Huang Q
    Front Mol Neurosci; 2020; 13():81. PubMed ID: 32581704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of deoxycytidine kinase (dCK) and glycogen synthase kinase (GSK-3β) by anti-CD20 (rituximab) and 2-chlorodeoxyadenosine (2-CdA) in human lymphoid malignancies.
    Al-Katib AM; Aboukameel A; Ebrahim A; Beck FW; Tekyi-Mensah SE; Raufi A; Ahmed Y; Mandziara M; Kafri Z
    Exp Hematol Oncol; 2014; 3():31. PubMed ID: 25937997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rebuilding synaptic architecture in HIV-1 associated neurocognitive disease: a therapeutic strategy based on modulation of mixed lineage kinase.
    Gelbard HA; Dewhurst S; Maggirwar SB; Kiebala M; Polesskaya O; Gendelman HE
    Neurotherapeutics; 2010 Oct; 7(4):392-8. PubMed ID: 20880503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase-3: A potential immunotherapeutic target in tumor microenvironment.
    Liang J; Yu M; Li Y; Zhao L; Wei Q
    Biomed Pharmacother; 2024 Apr; 173():116377. PubMed ID: 38442671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.